Clinical Trial Update: Bromfenac Sodium Hydrate Eye Drops in Familial Exudative Vitreoretinopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for bromfenac sodium hydride eye drops in familial exudative vitreoretinopathy is underway, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Exudative Vitreoretinopathy

Drugs mentioned

• Bromfenac Sodium Hydrate Eye Drops (bromfenac sodium hydrate)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Familial Exudative Vitreoretinopathies | Phase 2 | Status: UNKNOWN